awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52686509-46FBFE37-32A4-489B-9601-2C1CCA412B08
Q52686509-46FBFE37-32A4-489B-9601-2C1CCA412B08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52686509-46FBFE37-32A4-489B-9601-2C1CCA412B08
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma.
P2860
Q52686509-46FBFE37-32A4-489B-9601-2C1CCA412B08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52686509-46FBFE37-32A4-489B-9601-2C1CCA412B08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0375cf94e41f4da55011c13d6451974b9c4b2f7
P2860
Phase I/II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myeloma.